Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Breast magnetic resonance imaging: management of an enhancing focus.

Ha R, Comstock CE.

Radiol Clin North Am. 2014 May;52(3):585-9. doi: 10.1016/j.rcl.2014.01.001. Review.

PMID:
24792658
2.

Approach to breast magnetic resonance imaging interpretation.

Palestrant S, Comstock CE, Moy L.

Radiol Clin North Am. 2014 May;52(3):563-83. doi: 10.1016/j.rcl.2013.12.001. Review.

PMID:
24792657
3.

Management of breast magnetic resonance imaging-detected lesions.

Seely JM.

Can Assoc Radiol J. 2012 Aug;63(3):192-206. doi: 10.1016/j.carj.2010.11.003.

4.

Contrast-enhanced magnetic resonance imaging of the breast.

Helbich TH.

Eur J Radiol. 2000 Jun;34(3):208-19. Review.

PMID:
10927162
5.

Evaluation of clinical breast MR imaging performed with prototype computer-aided diagnosis breast MR imaging workstation: reader study.

Shimauchi A, Giger ML, Bhooshan N, Lan L, Pesce LL, Lee JK, Abe H, Newstead GM.

Radiology. 2011 Mar;258(3):696-704. doi: 10.1148/radiol.10100409.

PMID:
21212365
6.

[Value of MR-guided localization and biopsy in breast lesions].

Obenauer S, Grabbe E, Knollmann F.

Rofo. 2006 May;178(5):477-83. Review. German.

PMID:
16708322
7.

Screening breast MR imaging in women with a history of lobular carcinoma in situ.

Sung JS, Malak SF, Bajaj P, Alis R, Dershaw DD, Morris EA.

Radiology. 2011 Nov;261(2):414-20. doi: 10.1148/radiol.11110091.

PMID:
21900617
8.

MR imaging-guided interventions in the breast.

Lo LD, Orel SG, Schnall MD.

Magn Reson Imaging Clin N Am. 2001 May;9(2):373-80, vii. Review.

PMID:
11493426
9.

Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.

Choi N, Han BK, Choe YH, Kim HS.

J Comput Assist Tomogr. 2005 Nov-Dec;29(6):834-41.

PMID:
16272861
10.

Radiologic-pathologic correlation at breast MR imaging: what is the appropriate management for high-risk lesions?

Heller SL, Hernandez O, Moy L.

Magn Reson Imaging Clin N Am. 2013 Aug;21(3):583-99. doi: 10.1016/j.mric.2013.03.001. Review.

PMID:
23928247
11.

MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.

Orel SG, Rosen M, Mies C, Schnall MD.

Radiology. 2006 Jan;238(1):54-61.

PMID:
16304093
12.

Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.

Pediconi F, Padula S, Dominelli V, Luciani M, Telesca M, Casali V, Kirchin MA, Passariello R, Catalano C.

Radiology. 2010 Dec;257(3):653-61. doi: 10.1148/radiol.10100732.

PMID:
20884914
13.

Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation.

Mossa-Basha M, Fundaro GM, Shah BA, Ali S, Pantelic MV.

Radiographics. 2010 Oct;30(6):1673-87. doi: 10.1148/rg.306105510. Review. Erratum in: Radiographics. 2011 Jan-Feb;31(1):316.

PMID:
21071382
14.

MR-guided intervention in women with a family history of breast cancer.

Viehweg P, Bernerth T, Kiechle M, Buchmann J, Heinig A, Koelbl H, Laniado M, Heywang-Köbrunner SH.

Eur J Radiol. 2006 Jan;57(1):81-9.

PMID:
16364583
15.

Diffusion and perfusion of the breast.

Iacconi C.

Eur J Radiol. 2010 Dec;76(3):386-90. doi: 10.1016/j.ejrad.2010.03.009. Review.

PMID:
20413239
16.

MR-Guided vacuum biopsy of 206 contrast-enhancing breast lesions.

Perlet C, Schneider P, Amaya B, Grosse A, Sittek H, Reiser MF, Heywang-Köbrunner SH.

Rofo. 2002 Jan;174(1):88-95.

PMID:
11793291
17.

Characterization of the enhancing lesions on dynamic contrast enhanced magnetic resonance imaging in patients with interstitial mammoplasty.

Kim TY, Kim SH, Kang BJ, Kim HS, Cha ES, Kim JY, Song BJ.

Eur J Radiol. 2013 Dec;82(12):2205-11. doi: 10.1016/j.ejrad.2013.09.008.

PMID:
24103354
18.

MR-guided vacuum-assisted breast biopsy in the management of incidental enhancing lesions detected by breast MR imaging.

Carbognin G, Girardi V, Brandalise A, Baglio I, Bucci A, Bonetti F, Pozzi Mucelli R.

Radiol Med. 2011 Sep;116(6):876-85. doi: 10.1007/s11547-011-0631-7. English, Italian.

PMID:
21293942
19.

BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?

Bahrs SD, Baur A, Hattermann V, Hahn M, Vogel U, Claussen CD, Siegmann-Luz KC.

Acta Radiol. 2014 Apr;55(3):260-5. doi: 10.1177/0284185113501304.

PMID:
23969262
20.

Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.

Weinstein SP, Hanna LG, Gatsonis C, Schnall MD, Rosen MA, Lehman CD.

Radiology. 2010 Jun;255(3):731-7. doi: 10.1148/radiol.10081712.

Items per page

Supplemental Content

Support Center